In vitro antibacterial activity of OPS-2071 against Gram-positive and Gram-negative enteropathogenic bacteria.

Daisuke OkaRuchirada ChangkwanyeunTomoyuki YamaguchiChie NakajimaYasuhiko SuzukiMakoto Matsumoto

Published in: The Journal of antimicrobial chemotherapy (2022)

The broad and potent in vitro antibacterial activity and lower risk of drug resistance suggested that OPS-2071 may be useful for enteric infections caused by major pathogens including quinolone-resistant Campylobacter.

Keyphrases

gram negative
multidrug resistant
silver nanoparticles
antimicrobial resistance
biofilm formation
type iii
cystic fibrosis
candida albicans